11th May, 2017

01_0013_medopad

We are delighted to announce the kick-off of a new one-year pilot led by Chelsea and Westminster NHS Foundation Trust and based at the Cardiology Department of their West Middlesex site.

The pilot will focus on transforming heart failure patient care, re-assessing acute pathways whilst introducing a new home-based mHealth patient monitoring solution. At the same time, the pilot will assess patient care in the community, working closely with Hounslow CCG.

The digital health project component, supported by CW+ and delivered by the DigitalHealth.London Accelerator company Medopad, will allow remote patient monitoring, linking the West Middlesex Cardiology team to patient-reported feedback and wireless devices at home.

The power and impact of digital health is of course not just that of the technology itself. Rather, of the essence is how these solutions can interface with, complement, enhance and even transform the broader health service ecosystem, as a whole. This is where digital health stops being a silo-ed new technology and starts being an integral part of a new way of care.

Special thanks to Clinical Lead, Sadia Khan, her team and West Middlesex Cardiology, Hounslow CCG, Medopad stakeholders Dan Vahdat, Jesko Bartelt, Nick Hartshorne Evans and Novartis Patient Access Manager, Trevor Church, for invaluable support.

Special thanks to Chelsea and Westminster NHS FT Medical Director, Zoe Penn, and Associate Medical Director for Innovation and Service Transformation, Hugh Rogers, CW+ Finance Director, James Varley, for making this happen.

We would like to say thank you to our NHS Navigator, Lawrence Petalidis, for posting this story on LinkedIn.